Augmentation of Clozapine Due to Inadequate Treatment Response in Schizophrenia: Comparison of Patients with Augmented and Non-augmented Treatments

Senol S. H., Gurcan G., ERTUĞRUL A., KARAHAN S., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI, cilt.32, sa.1, ss.1-7, 2021 (SSCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5080/u25076
  • Dergi Adı: TURK PSIKIYATRI DERGISI
  • Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, MEDLINE, Psycinfo, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-7
  • Anahtar Kelimeler: Schizophrenia, clozapine, augmentation, treatment resistant, TREATMENT-RESISTANT SCHIZOPHRENIA, OBSESSIVE-COMPULSIVE SCALE, 2ND-GENERATION ANTIPSYCHOTICS, REFRACTORY SCHIZOPHRENIA, METAANALYSIS, RELIABILITY, EFFICACY, TURKISH
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Clozapine is considered to be a gold standard antipsychotic in treatment resistant schizophrenia. This study aims to investigate clozapine augmentation methods utilized in schizophrenia and compare the sociodemographic characteristics, clinical features and remission states of patients whose treatments are augmented and not.